Sanofi SA (SAN) Given a €95.00 Price Target at Deutsche Bank AG
Sanofi SA (EPA:SAN) has been given a €95.00 ($105.56) price objective by equities researchers at Deutsche Bank AG in a note issued to investors on Thursday. The firm presently has a a “buy” rating on the stock.
Other analysts also recently issued reports about the stock. Jefferies Group set a €74.00 ($82.22) target price on shares of Sanofi SA and gave the stock a “neutral” rating in a report on Thursday. Kepler Capital Markets set a €91.00 ($101.11) price target on shares of Sanofi SA and gave the company a “buy” rating in a report on Thursday, July 7th. JPMorgan Chase & Co. set a €71.00 ($78.89) price target on shares of Sanofi SA and gave the company a “sell” rating in a report on Thursday, September 15th. Berenberg Bank set a €93.00 ($103.33) price target on shares of Sanofi SA and gave the company a “buy” rating in a report on Thursday, September 8th. Finally, Societe Generale set a €100.00 ($111.11) price target on shares of Sanofi SA and gave the company a “buy” rating in a report on Monday, August 1st. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of €86.18 ($95.75).
Shares of Sanofi SA (EPA:SAN) traded down 0.47% during trading on Thursday, hitting €68.16. 2,751,758 shares of the company’s stock were exchanged. The firm has a 50-day moving average price of €25.96 and a 200-day moving average price of €25.76. The stock has a market cap of €87.72 billion and a P/E ratio of 21.19. Sanofi SA has a one year low of €22.81 and a one year high of €68.25.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/13/sanofi-sa-san-given-a-95-00-price-target-at-deutsche-bank-ag-2.html
Sanofi SA Company Profile
Sanofi, formerly Sanofi-Aventis, is a healthcare company engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company operates through three segments: Pharmaceuticals, Human Vaccines (Vaccines) and Animal Health. The Pharmaceuticals segment consists of research, development, production and marketing of medicines, including those originating from Genzyme Corporation.
Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with MarketBeat.com's FREE daily email newsletter.